Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

NVCT — Nuvectis Pharma, Inc. Dilution Risk Tracker

Track NVCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVCT — Get alerts when the score changes →

As of October 13, 2026, Nuvectis Pharma, Inc. (NVCT) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Nuvectis Pharma, Inc. has a market capitalization of $641.53M, 32.58M shares outstanding, 63 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NVCT.
🔔 Track NVCT — Get forecast alerts →

Market Data

Market Cap$641.53M
Shares Outstanding32.58M
Float15.38M
Cash$22.16M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding32.58MVerified float table or market cache
Public Float15.38MVerified float table or market cache
Market Cap$641.53MMarket data cache
Cash Runway13.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 20.0% shares (2026Q1 vs prior)
63 institutional holders · 5.33M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.32M shares
#2 BlackRock, Inc. 764.4K shares
#3 IRIDIAN ASSET MANAGEMENT LLC/CT 651.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.52M
Days to Cover10.3
% of Float16.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-02-25
xbrl XBRL CONVERTIBLE 2024-03-05
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NVCT Dilution Snapshot

Nuvectis Pharma, Inc. (NVCT) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NVCT's DilutionScore is currently 50/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 45/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202650/100MEDIUM53 days
Jul 16 – Aug 21, 202645/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NVCT shares outstanding have increased 0.1% from 26.49M (Apr 2026) to 26.53M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202626.53M15.38M▼ 0.60%
May 10, 202626.53M15.47M▼ 2.86%
May 09, 202626.53M15.93M▲ 3.04%
May 07, 202626.53M15.46M▲ 0.13%
Apr 11, 202626.49M15.44M▼ 0.35%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NVCT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NVCT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NVCT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NVCT
NVCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.